Cargando…
Ⅲa期非小细胞肺癌新辅助化疗的疗效分析及应用价值
BACKGROUND AND OBJECTIVE: The therapeutic effect and side effect of neoadjuvant chemotherapy were still disputing issues when applied to resectable Ⅲa stage non-small cell lung cancer (NSCLC) patients. The retrospective analysis was aimed to investigate the short-term efficacy and postoperative comp...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972975/ https://www.ncbi.nlm.nih.gov/pubmed/28228221 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.04 |
Ejemplares similares
-
新辅助免疫治疗联合化疗在可手术的非小细胞肺癌的初步疗效评估
Publicado: (2021) -
治疗前后NLR和PLR对进展期非小细胞肺癌一线化疗疗效及预后的预测价值
Publicado: (2018) -
Ⅰb期肺癌术后辅助化疗高风险因素分析
Publicado: (2014) -
EGFR突变状态对Ⅲ期非鳞非小细胞肺癌患者放化疗近期疗效和长期生存的预测价值
Publicado: (2011) -
术后辅助化疗对Ⅰ期非小细胞肺癌无瘤生存时间的影响
Publicado: (2017)